Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

50.67 +0.75 (+1.50%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,435,601
Open 49.87
Bid (Size) 50.60 (6)
Ask (Size) 50.71 (19)
Prev. Close 49.92
Today's Range 49.87 - 51.05
52wk Range 38.48 - 61.71
Shares Outstanding 5,606,688,356
Dividend Yield 3.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Contraceptives Market New Innovations Trends, Research, Global Share and Growth Factor
Contraceptives Market New Innovations Trends, Research, Global Share and Growth Factor The use of advanced contraceptive methods and emergency contraceptives methods, especially for teenagers, and... 
Via iCrowdNewswire
Topics Economy
Exposures COVID-19 Supply Chain
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR... 
Via iCrowdNewswire
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
-10.56%
-10.56%
1 Month
-2.26%
-2.26%
3 Month
+1.75%
+1.75%
6 Month
+2.05%
+2.05%
1 Year
+26.33%
+26.33%

More News

Read More
Insider Buying Remains Elevated For A Second Week $SBUX $UBER $RILY
Via Benzinga
Price Of Pfizer's Paxlovid Generic Version Capped At $25 Or Less For Low-Income Countries
Via Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, May 16
Via Benzinga
Pfizer/BioNTech COVID-19 Vaccine's European Delivery Takes Backseat To Help Booster Campaign
Via Benzinga
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Via Talk Markets
Johnson & Johnson Stock: A Rare Bright Spot in the Market
Via InvestorPlace
7 Profitable Places to Hide Your Money During a Bear Market
Via InvestorPlace
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
Via Benzinga
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
Via Investor's Business Daily
Stock Market Tries To Bounce From Fresh 2022 Lows; Tesla CEO Elon Musk Puts Twitter Deal 'On Hold': Weekly Review
Via Investor's Business Daily
7 Cheap Stocks to Buy Now for a Rich Retirement
Via InvestorPlace
COVID-19 Symptoms Rebound After Pfizer's COVID-19 Therapy, What Could Be The Reason?
Via Benzinga
INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus
Via InvestorPlace
Market Selloff
Via Talk Markets
5 Cryptos to Buy That Can Survive Market Bloodshed
Via InvestorPlace
103 Biggest Movers From Yesterday
Via Benzinga
Why Is Biohaven Pharmaceutical (BHVN) Stock Up Today?
Via InvestorPlace
Looking At Pfizer's Recent Whale Trades
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; Crude Oil Down 3%
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Lower; Biohaven Pharmaceutical Shares Jump
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.